Antineoplastic pharmaceuticals & immunosuppressive revenue in Argentina 2017-2022
In the fourth quarter of 2022, the antineoplastic and immunosuppressive pharmaceutical industry generated over 43.8 billion pesos in revenues in Argentina, up from around 39.8 billion pesos reported in the previous quarter. This figure has been constantly increasing since the beginning of 2020, when the antineoplastic pharmaceutical sector made more than 11.8 billion pesos in revenues in the South American country.